Icad Inc Stock Investor Sentiment

ICAD Stock  USD 2.02  0.04  1.94%   
About 62% of Icad's investor base is looking to short. The analysis of the overall investor sentiment regarding icad inc suggests that many traders are alarmed. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at finance.yahoo.com         
Investors in iCAD from three years ago are still down 63, even after 80 percent gain this past week
Yahoo News
over a year ago at thelincolnianonline.com         
iCAD Price Target Raised to 5.00
news
over a year ago at marketwatch.com         
iCAD Shares Rise 72 percent After Signing Agreement With Radiology Partners
marketwatch News
over a year ago at benzinga.com         
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nations Largest Radiology Pra...
benzinga news
over a year ago at finance.yahoo.com         
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nations Largest Radiology Pra...
Yahoo News
over a year ago at simplywall.st         
Shareholders in iCAD have lost 80, as stock drops 13 percent this past week
Simply Wall St News at Macroaxis
over a year ago at finance.yahoo.com         
iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Cleveland Clinic
Yahoo News
over a year ago at news.google.com         
Introducing the ProFound AI Suite Revolutionizing Breast Cancer ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Should You Buy iCAD Inc Stock After it Is Up 49.65 percent in a Week - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Artificial Intelligence in Oncology market is projected to grow at a CAGR of 43.6 percent by 2033 Vi...
Google News at Macroaxis
over a year ago at news.google.com         
Brachytherapy Seeds Market to reach US 191.4 million by 2031, growing at a CAGR of 4.1 percent from ...
Google News at Macroaxis
over a year ago at news.google.com         
Why Surgalign Holdings Shares Are Trading Lower By Around 75 ... - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
VEDU Announces Changes to Board of Directors - Visionary Education Tech - Benzinga
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Pura Vida Investments LLC Acquires 228,111 Shares of iCAD, Inc.
news
over a year ago at news.google.com         
BNP PARIBAS EXANE Upgrades ICADE - Nasdaq
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
iCAD adds US15m to market cap in the past 7 days, though investors from three years ago are still down 82
10/17/2024
2
Acquisition by Hricak Hedvig of 40000 shares of Icad at 1.36 subject to Rule 16b-3
11/05/2024
3
iCAD Non-GAAP EPS of -0.07 beats by 0.01, revenue of 4.2M misses by 0.42M
11/13/2024
4
icad Inc Q3 2024 Earnings Call Highlights Revenue Growth Amidst Strategic Shifts
11/14/2024
5
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
11/26/2024
6
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA ...
12/04/2024
7
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial Calcifications Assessment Across Diverse Populations
12/11/2024
8
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell
01/03/2025

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences